Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)

23.23 -0.43 (-1.82%) At close: 03:04PM CST

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

No. 636, Zhiyuan North Road
Wukang Town Deqing County
Huzhou 313200
China
86 57 2883 1088
https://www.wolwobiotech.com

Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full-time employees: 1,709

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Gengxi Hu	Chairman & GM	N/A	N/A	1964
Ms. Lu Zhang	Deputy GM & Non-Independent Director	N/A	N/A	1979
Mr. Ziqiang Bi	Deputy GM & Non-Independent Director	N/A	N/A	1964
Mr. Jianming He	Deputy General Manager	N/A	N/A	1986

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a farinae farinae drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kits; and Changdian II, a house dust mite skin pricking diagnostic kits. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 and is headquartered in Huzhou, China.

Corporate governance

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.